Zonisamide Enhances Motor Effects of Levodopa, Not of Apomorphine, in a Rat Model of Parkinson’s Disease

Zonisamide Enhances Motor Effects of Levodopa, Not of Apomorphine, in a Rat Model of Parkinson’s Disease

Zonisamide is a relatively recent drug for Parkinson’s disease. Multiple hypotheses have been proposed to explain the antiparkinsonian effects of zonisamide. However, it is still unclear whether the effect of zonisamide is mainly due to dopaminergic modification in the striatum, or if zonisamide wor...

Full description

Saved in:

Bibliographic Details
Main Authors:	Haruo Nishijima, Yasuo Miki, Shinya Ueno, Masahiko Tomiyama
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	Parkinson's Disease
Online Access:	http://dx.doi.org/10.1155/2018/8626783
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Somatosensory Evoked Potentials and Dopaminergic Responsiveness to Apomorphine and Levodopa in Parkinsonian Patients
by: M. Miranda, et al.
Published: (1996-01-01)

Cost-Effectiveness of Apomorphine Sublingual Film as an “On-Demand” Treatment for “OFF” Episodes in Patients with Parkinson's Disease
by: Andrew Thach, et al.
Published: (2021-11-01)

Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa
by: Cindy Zadikoff, et al.
Published: (2020-01-01)

The Parkinson’s Disease Composite Scale Is Adequately Responsive to Acute Levodopa Challenge
by: Dávid Pintér, et al.
Published: (2019-01-01)

Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease
by: J. Guridi, et al.
Published: (2012-01-01)

Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson’s Disease with Motor Fluctuations
by: John C. Morgan, et al.
Published: (2018-01-01)

Synergistic action of propolis with levodopa in the management of Parkinsonism in Drosophila melanogaster
by: Herbert Izo, Ninsiima, et al.
Published: (2020)

Sleep Quality and Levodopa Intestinal Gel Infusion in Parkinson’s Disease: A Pilot Study
by: Oriol De Fabregues, et al.
Published: (2018-01-01)

Rasagiline as Adjunct to Levodopa for Treatment of Parkinson’s Disease: A Systematic Review and Meta-Analysis
by: Osamu Kano, et al.
Published: (2022-01-01)

Levodopa Responsive Parkinsonism in Patients with Hemochromatosis: Case Presentation and Literature Review
by: Tarun Girotra, et al.
Published: (2017-01-01)

Wearable Sensors Measure Ankle Joint Changes of Patients with Parkinson’s Disease before and after Acute Levodopa Challenge
by: Zhuang Wu, et al.
Published: (2020-01-01)

Effect of Intestinal Levodopa-Carbidopa Infusion on Pharyngeal Dysphagia: Results from a Retrospective Pilot Study in Patients with Parkinson’s Disease
by: Bendix Labeit, et al.
Published: (2020-01-01)

Carbidopa/levodopa dose elevation and safety concerns in Parkinson's patients: a cross-sectional and cohort design
by: Michael S Okun, et al.
Published: (2012-12-01)

L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson’s Disease: A Randomised Study
by: Fabrizio Stocchi, et al.
Published: (2015-01-01)

Quantitative Analysis of Motor Status in Parkinson’s Disease Using Wearable Devices: From Methodological Considerations to Problems in Clinical Applications
by: Masahiko Suzuki, et al.
Published: (2017-01-01)

Clinical Aspects and Management of Levodopa-Induced Dyskinesia
by: Nicola Tambasco, et al.
Published: (2012-01-01)

Genetic Rat Models of Parkinson's Disease
by: Ryan M. Welchko, et al.
Published: (2012-01-01)

Progression of Nonmotor Symptoms in Parkinson’s Disease by Sex and Motor Laterality
by: Zimple Kurlawala, et al.
Published: (2021-01-01)

Non-motor Disorders and their Neuro-anatomical Substrate in Parkinson's Disease
by: Julio López Argüelles, et al.
Published: (2024-12-01)

Long-Term Voluntary Physical Exercise Exerts Neuroprotective Effects and Motor Disturbance Alleviation in a Rat Model of Parkinson’s Disease
by: Wan-Ling Tsai, et al.
Published: (2019-01-01)

Cannabis oil in treating Parkinson’s disease: improvement of motor and non-motor symptoms: a case report
by: C. T. M. I. Issa, et al.
Published: (2025-01-01)

IT diagnostics of Parkinson's disease based on voice markers and decreased motor activity
by: U. V. Vishniakou, et al.
Published: (2024-01-01)

CHRONOTYPE AND DAILY FUNCTIONING OF PATIENTS WITH DIFFERENT MOTOR SUBTYPES OF PARKINSON DISEASE
by: A.D. Shkodina, et al.
Published: (2024-04-01)

Association of Specific Leg Muscle Strength and Motor Features in Parkinson’s Disease
by: Chatkaew Pongmala, et al.
Published: (2024-01-01)

Relation of Subjective Quality of Life to Motor Symptom Profile in Parkinson's Disease
by: Erica R. Appleman, et al.
Published: (2011-01-01)

Confirmatory Factor Analysis of the Motor Unified Parkinson’s Disease Rating Scale
by: Stefanie D. Vassar, et al.
Published: (2012-01-01)

Iron deposition is associated with motor and non-motor network breakdown in parkinsonism
by: Fangda Leng, et al.
Published: (2025-01-01)

Learning “How to Learn”: Super Declarative Motor Learning Is Impaired in Parkinson’s Disease
by: Lucio Marinelli, et al.
Published: (2017-01-01)

Multimodal magnetic resonance imaging studies on non-motor symptoms of Parkinson's disease
by: Weimin Qi, et al.
Published: (2025-06-01)

The Effect of Hyperhomocysteinemia on Motor Symptoms, Cognitive Status, and Vascular Risk in Patients with Parkinson’s Disease
by: Bilge Kocer, et al.
Published: (2016-01-01)

Clinically probable RBD is an early predictor of malignant non-motor Parkinson’s disease phenotypes
by: Alfonso Enrique Martinez-Nunez, et al.
Published: (2025-01-01)

Transfection of the BDNF Gene in the Surviving Dopamine Neurons in Conjunction with Continuous Administration of Pramipexole Restores Normal Motor Behavior in a Bilateral Rat Model of Parkinson’s Disease
by: Alina Benítez-Castañeda, et al.
Published: (2024-01-01)

Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson’s Disease? The Potential Role of Zolpidem in the Treatment of Parkinson’s Disease
by: Antonio Daniele, et al.
Published: (2016-01-01)

Neurocognitive Rehabilitation in Parkinson’s Disease with Motor Imagery: A Rehabilitative Experience in a Case Report
by: Federico Zangrando, et al.
Published: (2015-01-01)

The Influence of Parkinson’s Disease Motor Symptom Asymmetry on Hand Performance: An Examination of the Grooved Pegboard Task
by: Sara M. Scharoun, et al.
Published: (2015-01-01)

Deep Brain Stimulation in Parkinson’s Disease: New and Emerging Targets for Refractory Motor and Nonmotor Symptoms
by: Dustin Anderson, et al.
Published: (2017-01-01)

The Influence of Playing a Non-Reward Game on Motor Ability and Executive Function in Parkinson’s Disease
by: Alisson Menezes Araújo Lima, et al.
Published: (2012-01-01)

VMAT2-Deficient Mice Display Nigral and Extranigral Pathology and Motor and Nonmotor Symptoms of Parkinson's Disease
by: Tonya N. Taylor, et al.
Published: (2011-01-01)

In silico analysis of hub genes and regulatory networks implicates the putamen in non-motor Parkinson’s disease disorders
by: Stephen Tunmise Akanbi, et al.
Published: (2025-01-01)

Dynamic Neuro-Cognitive Imagery Improves Mental Imagery Ability, Disease Severity, and Motor and Cognitive Functions in People with Parkinson’s Disease
by: Amit Abraham, et al.
Published: (2018-01-01)